Internal Medicine
The Emerging Spectrum of COVID-19 Neurology: Clinical, Radiological and Laboratory Findings
9 Jul, 2020 | 09:25h | UTCThe emerging spectrum of COVID-19 neurology: clinical, radiological and laboratory findings – Brain
Commentaries: The coronavirus may cause brain damage, even in patients with mild cases, a new study found – Business Insider AND Scientists warn of potential wave of COVID-linked brain damage – Reuters AND Coronavirus pandemic could cause wave of brain damage, scientists warn – CNN
[Abstract Only] Randomized Trial: Baloxavir Marboxil for Prophylaxis against Influenza in Household Contacts
9 Jul, 2020 | 09:22h | UTCCommentary: Baloxavir Helps Prevent Flu in Exposed Household Contacts – NEJM Journal Watch
Randomized Trial: Probiotic Use Does Not Reduce Antibiotic Administration Among Care Home Residents
9 Jul, 2020 | 09:20h | UTCCommentary: Probiotics do not reduce antibiotic prescribing in care home residents, shows study – University of Oxford
Related Commentary on Twitter
There is no evidence that #probiotics reduce antibiotic administration for acute infections in care home residents, finds PRINCESS Trial published today in @JAMA_current#carehomes
➡️https://t.co/7yEpKA3rp9 pic.twitter.com/xnthh0bLWK
— OxPrimaryCareSci (@OxPrimaryCare) July 7, 2020
Cohort Studies: Intake of Whole Grain Foods and Risk of Type 2 Diabetes
9 Jul, 2020 | 09:18h | UTC
Related Commentary on Twitter
Higher consumption of fruit, vegetables and whole grain foods are associated with a lower risk of developing type 2 diabetes, according to two studies published by @bmj_latest today https://t.co/bL3fF8nThC https://t.co/gD2dfhwAmf
— BMJ Group (@bmj_company) July 9, 2020
Study: Association of Plasma Biomarkers of Fruit and Vegetable Intake with Incident Type 2 diabetes
9 Jul, 2020 | 09:16h | UTCCommentary: Higher fruit, vegetable and whole grain intake linked to lower risk of diabetes – British Medical Journal
Related Commentary on Twitter
This study suggests that even a modest increase in fruit and vegetable intake could help to prevent type 2 diabetes, indicated by objective biomarkers of consumption, regardless of whether the increase is among people with initially low or high intake https://t.co/g9TXm9TaeE
— The BMJ (@bmj_latest) July 9, 2020
In a New Hospital Ranking, Doing Good Counts Nearly as Much as Doing Well
8 Jul, 2020 | 00:58h | UTCIn a new hospital ranking, doing good counts nearly as much as doing well – STAT
Lown Institute Hospital Index: Hospitals Serve Individuals AND Communities
See also: Introducing the Best Hospitals for America – Washington Monthly
Related Commentary on Twitter
Why won't you find elite hospitals like the Mayo Clinic or Mass General at the top of the #LownHospitalsIndex?
Because many hospitals achieving the best patient outcomes aren't doing as much as they could to promote health equity and avoid overuse. https://t.co/MRSGkfya5I
— Lown Institute (@lowninstitute) July 7, 2020
Methotrexate is Not an Additional Risk Factor for Interstitial Lung Disease in RA Patients
8 Jul, 2020 | 00:54h | UTCRelated Review: Treatment of Rheumatoid Arthritis-Associated Interstitial Lung Disease: Lights and Shadows – Journal of Clinical Medicine
New USPSTF Draft Statement Now Recommends Lung Cancer Screening Beginning at Age 50 Among People at High Risk
8 Jul, 2020 | 00:56h | UTCDraft Recommendation Statement: Lung Cancer Screening – U.S Preventive Services Task Force
Commentaries: Proposed changes to lung cancer screening guidance could increase scans among Black patients, women – STAT
It is Time to Address Airborne Transmission of COVID-19
7 Jul, 2020 | 09:04h | UTCIt is Time to Address Airborne Transmission of COVID-19 – Clinical Infectious Diseases
Commentaries: Global experts: Ignoring airborne COVID spread risky – CIDRAP AND Coronavirus can float in air and WHO and CDC should tell people that, experts say – CNN AND Expert reaction to commentary about potential airborne transmission of the SARS-CoV-2 virus – Science Media Centre
Clinical Practice Guideline: Treatment of Nontuberculous Mycobacterial Pulmonary Disease
7 Jul, 2020 | 08:53h | UTC
Study Addresses Clinical Validity and Utility of Serum Antibodies to SARS-CoV-2
7 Jul, 2020 | 08:55h | UTC
A Comprehensive Review of Manifestations of Novel Coronaviruses in the Context of Deadly COVID-19 Global Pandemic
7 Jul, 2020 | 08:54h | UTC
Study: Palliative Care in Terminal Non-cancer Illnesses Linked to Reduction in the Rate of Emergency Department Visits, Hospital Admissions, and Intensive Care Unit Admissions
7 Jul, 2020 | 08:45h | UTC
Guideline on Screening for Esophageal Adenocarcinoma in Patients with Chronic GERD
7 Jul, 2020 | 08:46h | UTCSummary: recommendations for clinicians and policy-makers – Canadian Task Force on Preventive Health Care
Podcast: A Clinical Pharmacologist’s Perspective on Penicillin Allergy
7 Jul, 2020 | 08:43h | UTCA Clinical Pharmacologist’s Perspective on Penicillin Allergy – JAMA
Study Publications Must Be Up-To-Date in Covid Time (Regarding the Latest Observational Hydroxychloroquine Study)
6 Jul, 2020 | 09:00h | UTCStudy Publications Must Be Up-To-Date in Covid Time – Absolutely Maybe Blog, by Hilda Bastian
Opinion – One U.K. Trial is Transforming COVID-19 Treatment. Why Haven’t Others Delivered More Results?
6 Jul, 2020 | 08:58h | UTCStudy 1 – lopinavir-ritonavir: No clinical benefit from use of lopinavir-ritonavir in hospitalised COVID-19 patients studied in RECOVERY
Study 2 – dexamethasone: Low-cost dexamethasone reduces death by up to one third in hospitalised patients with severe respiratory complications of COVID-19 – Recovery Trial AND Effect of Dexamethasone in Hospitalized Patients with COVID-19: Preliminary Report – medRxiv
Study 3 – hydroxychloroquine: No clinical benefit from use of hydroxychloroquine in hospitalised patients with COVID-19
WHO Discontinues Hydroxychloroquine and Lopinavir/Ritonavir Treatment Arms for COVID-19
6 Jul, 2020 | 09:02h | UTCCommentary: WHO says trials show malaria and HIV drugs don’t cut Covid-19 hospital deaths – The Guardian
Related Commentary on Twitter
WHO accepted the recommendation from the Solidarity Trial’s International Steering Committee to discontinue the trial’s hydroxychloroquine and the lopinavir/ritonavir arms.
More https://t.co/dCxHqBIwtr#COVID19 #coronavirus
— World Health Organization (WHO) (@WHO) July 4, 2020
239 Experts With 1 Big Claim: The Coronavirus Is Airborne
6 Jul, 2020 | 08:57h | UTC239 Experts With 1 Big Claim: The Coronavirus Is Airborne – The New York Times
“… in an open letter to the W.H.O., 239 scientists in 32 countries have outlined the evidence showing that smaller particles can infect people, and are calling for the agency to revise its recommendations. The researchers plan to publish their letter in a scientific journal next week.”
Six Months of Coronavirus: The Mysteries Scientists are Still Racing to Solve
6 Jul, 2020 | 08:41h | UTCSix months of coronavirus: the mysteries scientists are still racing to solve – Nature
[Preprint] Randomized Trial: Convalescent Plasma for COVID-19
6 Jul, 2020 | 08:47h | UTCConvalescent Plasma for COVID-19. A randomized clinical trial – medRxiv
Related Commentary on Twitter
https://twitter.com/hildabast/status/1279625347214921729
Meta-Analysis: Acute Complications and Mortality in Hospitalized Patients with Covid-19
6 Jul, 2020 | 08:36h | UTC
Randomized Trial: Thulium Laser Transurethral Vaporesection of the Prostate vs. Transurethral Resection for Men with Lower Urinary Tract Symptoms or Urinary Retention
6 Jul, 2020 | 08:31h | UTCInvited Commentary: Surgery for benign prostatic obstruction
Meta-analysis: The Safety and Efficacy of Aspirin Discontinuation on a Background of a P2Y12 Inhibitor in Patients after Percutaneous Coronary Intervention
6 Jul, 2020 | 08:27h | UTCCommentaries: Short DAPT Reduces Bleeding With No Increase in MACE: Meta-analysis – TCTMD AND Discontinuing Aspirin on Background of P2Y12 Inhibitor After PCI – American College of Cardiology
Covid-19: Viral Loads in Upper Respiratory Specimens Peak by 2-3 Days from Symptom Onset and Decrease Rapidly Thereafter
3 Jul, 2020 | 08:40h | UTC
Related Commentary on Twitter
Distribution of Transmission Potential during Non-Severe COVID-19 Illness https://t.co/w5lfg50ZXj. Elegant study from @ClevelandClinic suggesting in non-severe COVID-19, viral loads in upper resp specimens peak by 2-3 days from symptom onset and decrease rapidly thereafter.
— Carlos del Rio (@CarlosdelRio7) July 2, 2020